UTI AMC H1 FY27: Core PAT up 15% to ₹263 cr as Group AUM falls 27% after EPFO mandate reallocation
H1 FY27 consolidated Core PAT up 15% to ₹263 cr, Core EBITDA up 14%; Group AUM down 27% YoY to ₹16,28,189 cr.
By ScoutQuest · · 1 min read
- Core PAT (H1 FY27)
- up 15% to ₹263 cr
- Core EBITDA (H1 FY27)
- up 14%
- Group AUM
- down 27% YoY to ₹16,28,189 cr
- Period
- Quarter and half year ended 30th September 2026
- Positioning
- UTI AMC describes itself as a group managing ₹16,28,189 cr of AUM across mutual funds, PMS, international, alternatives and pension funds, with 256 UTI Financial Centres and five offshore locations.
📉 Consolidated H1 FY27 total income was ₹985 cr (up 2% YoY), core revenue ₹777 cr (up 1%), core EBITDA ₹367 cr (up 14%) and core PAT ₹263 cr (up 15%). Standalone Q2 FY27 PAT fell 14% YoY to 143 cr while core PAT rose 31% to 136 cr.
📉 Total Group AUM fell 27% YoY to ₹16,28,189 crore; the presentation attributes the decline to EPFO's February 2026 reallocation of assets after it expanded its fixed income mandate from two managers to four. UTI MF QAAUM rose 6.32% YoY to ₹4,02,337 cr, behind industry growth of 13.06%.
📉 Index and ETF QAAUM grew 15.61% YoY to 1,87,807 crore while equity QAAUM slipped 0.52% and income fell 16.56%; equity market share eased to 2.54% from 2.93%. H1 FY27 total net sales were 20,039 crore, led by ETFs & Index and Cash & Arbitrage.
📌 The company says UTI Alternatives has total cumulative commitments of ₹7,004 crore with active commitments of ₹4,045 crore, and states it is currently raising and deploying from MOF II (₹360 crore commitments) and SDOF IV (INR 1131 Cr).
Also from UTI Asset Management Company
UTI Asset Management Company Ltd press release, Q2 FY27
23 Oct 2026
UTI AMC H1 FY27: Core PAT up 15% to ₹263 cr as group AUM falls 27% after EPFO reallocation
23 Oct 2026
Board meeting outcome: unaudited Q2 and H1 results approved, auditor's limited review conclusion
23 Oct 2026
More numbers
- Total Group AUM, September 2026₹ 16,28,189 cr
- Total Group AUM YoY change(27%)
- UTI MF QAAUM, Q2 FY27₹ 4,02,337 cr
- Total Income, consolidated H1 FY27₹ 985 cr
- Core EBITDA, consolidated H1 FY27₹ 367 cr
- Core PAT, consolidated H1 FY27₹ 263 cr
- Core PAT YoY growth, H1 FY2715%
- Market share, total MF QAAUM4.61%
- Index and ETFs QAAUM, Sep'261,87,807 (₹ crore)
- Total net sales, H1 FY2720,039 (₹ crore)
- Standalone PAT, Q2 FY27143 (In cr.)
- UTI Alternatives total cumulative commitments₹ 7,004 crore
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.